Constipation is another common issue, reported in 21-25% of retatrutide users and a significant percentage of cagrilintide users
The combined protocols cost-per-outcome ratio is superior because it addresses the rate-limiting variables that prevent either compound from reaching maximum efficacy alone
Percent Daily Reference Intakes (RI) not established
It is important to keep in mind, however, that some of these substances may have pharmacological limitations, including the mechanism of drug action, administration route, tolerability, side effects, and proven efficacy, that should be considered before they could be approved for its use in this pathology
It pairs a top-of-class metabolic peptide with a much smaller peptide that targets the cellular layer of fat burning